Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.116NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.526NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.273NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.13 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.358NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.159NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.510NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.91NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.227NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.555NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.513NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HN.4.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XACNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EJ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.31.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
BQ.1.1.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.367NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.244NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JD.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used